A Human Enteroid Model of Cholera Toxin Pathophysiology
A Human Enteroid Model of Cholera Toxin Pathophysiology
批准号:
10062959
负责人:
Jennifer Foulke-Abel
金额:
$15.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-09 至 2022-11-30
关键词:
3-DimensionalAcuteAcute DiarrheaAddressAdultAdvisory CommitteesAffectAgonistAnimal ModelApicalBioinformaticsCRISPR/Cas technologyCell CycleCell Cycle ArrestCell Cycle RegulationCell LineageCell SeparationCell surfaceCellsCholeraCholera ToxinCholera Toxin Protomer BCrowdingCyclic AMPDataDetectionDevelopmentDiarrheaDinoprostoneDiseaseDisease OutbreaksDrosophila genusEP4 receptorEnteralEnterochromaffin CellsEnterochromaffin-like CellsEnterocytesEnteroendocrine CellEnterotoxinsEnvironmentEnzyme-Linked Immunosorbent AssayEpithelialEpithelial CellsEvaluationExhibitsExposure toFluids and SecretionsFosteringFunctional disorderGastroenterologyGenesGenetic TranscriptionGoalsGoblet CellsGrowth FactorHomeostasisHumanIL8 geneImmuneInflammationInflammatoryInfrastructureInnate Immune ResponseIntentionIntestinal MucosaIntestinesKnock-outKnowledgeLifeLinkLiquid substanceMediatingMentorsMethodsMidgutModelingNF-kappa BPatientsPharmacologyPharmacotherapyPhasePopulationProcessProductionProfessional RolePublic HealthRecoveryReportingResearchResearch PersonnelResourcesRestRoleSaltsSanitationScientistSerotoninSeveritiesSeverity of illnessSignal TransductionSymptomsTLR4 geneTNF geneTechnical ExpertiseTechniquesTestingUniversitiesVariantVibrio choleraeVibrio cholerae infectionVillusadult stem cellcell dimensioncell motilitycell typeclinically significantcytokinediarrheal diseaseexperienceextracellularimmune activationinhibitor/antagonistinsightintestinal epitheliummedical schoolsmonolayernovelpathogenic microbepreventprototypereceptorrecruitresponserole modelserotonin receptorserotonin transporterskill acquisitionstemstem cell populationstem cellssymptom managementtranscriptome sequencingtransmission processtwo-dimensional
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Vibrio cholerae infection continues to be a life-threatening concern in regions with crowded living conditions
and poor sanitation. The emergence of El Tor variant, a strain that exhibits enhanced cholera toxin (CT)
production and innate immune activation, necessitates examination of the factors that contribute to increased
disease severity in recent outbreaks. CT elicits production and secretion of prostaglandin E2 (PGE2), serotonin
(5-HT), and numerous cytokines that may not only regulate intestinal fluid transport, but may also contribute to
the innate immune response. In our novel observation, the CT B subunit was found to induce cell cycle arrest
in actively dividing intestinal stem/progenitor cells, and we hypothesize that this phenomenon may arise from
the same signaling that yields PGE2, 5-HT, cAMP, or cytokine release. To facilitate mechanistic studies of CT-
induced biomolecule secretion and cell cycle arrest, we will employ primary untransformed human enteroids
derived from adult stem cells of the intestine. We have developed a method to grow human enteroids as 2-
dimensional epithelial monolayers, overcoming the limitation of 3-dimensional cultures that prevents direct
access to the polarized apical cell surface. This K01 proposal will establish understanding of CT-mediated
innate immune response and cell cycle dysregulation using the enteroid monolayer model in the following
aims: We will 1) identify how CT induces PGE2 synthesis and IL-8 secretion through CRISPR/Cas9-
guided receptor knock-outs, pharmacological inhibitor studies, and secreted PGE2 and cytokine ELISA. Using
a recently reported method to enrich enteroid cultures with the enterochromaffin cell lineage, we will 2)
determine how CT increases extracellular 5-HT and how this contributes to cytokine release. This will
include evaluation of direct or indirect stimulation of 5-HT secretion, function of the serotonin transporter
(SERT), and enterocyte 5-HT receptor roles in cytokine production. Finally, we will 3) determine the origin
and duration of CT-induced cell cycle arrest using EdU incorporation, FACS analysis of cell cycle phase,
and RNA-Seq to compare transcriptional changes induced by CT, CTB, PGE2, 5-HT, cAMP, and specific
cytokines. Not only will these aims advance understanding of CT-induced pathophysiology with potential
clinical significance, but they will also foster technical skill development in cytokine detection/quantitation,
CRISPR/Cas9-driven gene editing, and computational bioinformatics to analyze RNA-Seq data. My advisory
committee of highly qualified scientific and professional role models and the resource-rich environment in the
Division of Gastroenterology at the Johns Hopkins University School of Medicine will guide my development
from a mentored researcher to an independent scientist in the field of diarrheal diseases and intestinal stem
cell effects caused by enteric microbial pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Human Enteroid Model of Cholera Toxin Pathophysiology
-
批准号:10303063
-
项目类别:
-
资助金额:$15.82万
-
财政年份:2018
-
负责人:Jennifer Foulke-Abel
-
依托单位:
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors
-
批准号:10686839
-
项目类别:
-
资助金额:$46.14万
-
财政年份:2016
-
负责人:Jennifer Foulke-Abel
-
依托单位:
Pathogenesis of E. coli and Shigella infections in human enteroid models
-
批准号:10686819
-
项目类别:
-
资助金额:$213.92万
-
财政年份:2016
-
负责人:Jennifer Foulke-Abel
-
依托单位:
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors
-
批准号:10427394
-
项目类别:
-
资助金额:$42.45万
-
财政年份:2016
-
负责人:Jennifer Foulke-Abel
-
依托单位:
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors
-
批准号:10745567
-
项目类别:
-
资助金额:$3.88万
-
财政年份:2016
-
负责人:Jennifer Foulke-Abel
-
依托单位:
Innate defenses against enterotoxigenic E. coli as potential therapeutic contributors
-
批准号:10190304
-
项目类别:
-
资助金额:$35.19万
-
财政年份:2016
-
负责人:Jennifer Foulke-Abel
-
依托单位:
海外基金